Zoe is currently Deputy CEO at the health innovation network – the AHSN for south London. The HIN’s purpose is to drive the uptake of innovation in the health and care sector, in order to improve the outcomes and experience of patients, and to support economic growth in health and care related businesses.
Zoe leads on the work of the HIN’s clinical programmes, including Diabetes, AF Stroke Prevention, Musculoskeletal, Mental Health, Healthy Ageing and Patient Safety, and works closely with academic partners (King’s Health Partners AHSC and the south London CLAHRC) as well as local Sustainability and Transformation Partnerships. She also works with colleagues nationally supporting spread and adoption programmes across the 15 AHSNs.
Before taking up her role at the HIN, Zoe worked at KHP in planning and research management, alongside her role as Deputy Director of Strategy at King’s College Hospital. Prior to that she held a number of general management roles at Barts Health.
Tony Rudd is Professor of Stroke Medicine at Kings College London and the National Clinical Director for Stroke for NHS England. He runs the stroke programme producing national stroke guidelines and the national audit (SSNAP). His research interests are stroke rehabilitation, organisation of care and quality improvement with over 300 peer reviewed publications. He was made a CBE in the Queen’s Birthday Honours in 2013.
Faye is the National Programme Manager for the Atrial Fibrillation (AF) Programme across the 15 Academic Health Science Networks, she oversees the AF programme across the three programme elements; Detect, Protect and Perfect. This includes the national roll out of AF detection devices, raising public awareness of AF, improving the quality of anticoagulation services and the spread and adoption of best practice in AF nationwide.
Sotiris is Consultant Pharmacist at Barts Heart Centre, part of Barts Health NHS Trust. Combined with his role as Lead Cardiovascular Pharmacist for UCL Partners supports medicines optimisation across the health economy to optimise patient outcomes and address unmet local needs.
He is an independent prescriber and is currently chair of the cardiac committee for United Kingdom Clinical Pharmacy Association (UKCPA). He is chair of the international Pharmacist Anticoagulation Taskforce (iPACT). An international group of over 20 countries aimed to improve pharmaceutical care around anticoagulants, by providing background materials and stimulating pharmacists to provide appropriate care to their patients. Sotiris is also a member of the Atrial Fibrillation Association medical advisory panel.
He has published extensively in the medical press and has a particular interest in in improving anticoagulation for stroke prevention in atrial fibrillation. Sotiris has been successful in obtaining a Lord Darzi funded fellow to ‘co-design and test a new referral pathway for people with atrial fibrillation with community pharmacists’ with the aim to support individuals understanding of their condition and their therapy with the ultimate aim of optimising adherence. Sotiris is also a member of the ‘AF-SCREEN International collaboration’ that produced a white paper titled ‘Screening for Atrial Fibrillation’. The AF-SCREEN international collaboration was formed in September 2015 to promote discussion and research about AF screening as a strategy to reduce stroke and death and to provide advocacy for implementation of country-specific AF screening programs.
He is actively involved in the training and development of clinical pharmacists including developing a curriculum and assessment tool for advanced and consultant level specialist cardiac pharmacists working with the UKCPA and Royal Pharmaceutical Society.
Sotiris has served on many NICE development groups including Unstable Angina/NSTEMI guideline, stable angina and STEMI guidelines and is a current NICE TA member of the highly specialist technology appraisal group. He is also a member of the London Strategic Clinical Network Cardiovascular Leadership Group and NHS England Medicines Optimisation Intelligence Group meeting. Sotiris is also an honorary senior research associate at UCL School of Pharmacy.
Diviash Thakrar has been a frontline GP since 1999 and he enjoys the hustle and bustle of GP life. He is a GPSI in cardiology working at Hillingdon and community since 2002. At present the clinical lead for Cardiology in Hillingdon Cardiology CCG . He enjoys the thought of taking a step back and reflecting on the bigger picture to delivering care in a way it makes a difference.
He is an appraiser and has written a book called ‘Caring for Hindu patients’ which include a few articles.
In his spare time he enjoys walking and swimming and voluntary community work.
Dr Matt Kearney is a general practitioner and National Clinical Director for Cardiovascular Disease Prevention in England. He has been working for both NHS England and Public Health England since 2013, building a national programme to improve prevention of cardiovascular disease. In particular, he has focused on mobilising the wider primary care system to support earlier detection and improved management of conditions such as hypertension, atrial fibrillation, and raised cholesterol.
From 2009 to 2014, Matt worked as an advisor to the Department of Health helping develop a national respiratory strategy, and from 2005 to 2013, was a member of Public Health Interventions Advisory Committee at the National Institute for Health and Care Excellence. He graduated in Medicine from the University of Birmingham and obtained a Master's Degree in Public Health from the University of Liverpool in 2003. He is a Fellow of the Royal College of Physicians and a Fellow of the Royal College of General Practitioners.
Consultant Pharmacist for Cardiovascular Disease, South London, UK
National Clinical Adviser for AF, AHSN Network
Clinical Director for AF, Health Innovation Network
Clinical Lead for Cardiovascular Disease, Southwark and Lambeth CCGs
As Consultant Pharmacist for CVD Disease, Helen is involved in a wide range of activities across South London to improve the care of patients with or at risk of cardiovascular disease (CVD). Helen chairs the local cardiovascular medicines working group which develops and supports the implementation of consensus evidence-based guidance for use across South London’s 12 clinical commissioning groups and 7 acute trusts, covering a population of 3.6million. Currently, there is a strong focus on medicines optimisation in primary care for long terms conditions such as heart failure, hypertension and atrial fibrillation with the aim of reducing the burden of acute hospital admissions and she has been involved in supporting primary care practitioners through guideline implementation, clinical audit and provision of pharmacist-led virtual clinics. A key focus over recent years has been to increase the proportion of patients with AF who are anticoagulated to reduce the incidence of AF-related stroke.
Helen is also the clinical lead for CVD within two South London CCGs, Clinical Director for AF in the local Health Innovation Network, National Clinical Adviser to the collaborative AF programme of the 15 Academic Health Science Networks across England and also co-chair of the Pan-London stroke prevention in Atrial Fibrillation strategy group. In addition, Helen is an editorial board member for the British Journal of Cardiology and the Journal of Medicines Optimisation, has worked with NICE on the development of a number of cardiovascular guidelines and is a member of the NHS England Primary Care Cardiovascular Leadership Forum and the London Cardiovascular and Stroke Strategic Clinical Leadership Groups.
Dr Frances Akor FFRPS MRPharmS
Frances commenced work in anticoagulation in 2002 with a PhD exploring the evidence-based redesign of anticoagulation services in different care settings.
Over the years, Frances has redesigned and delivered a variety of anticoagulation service models in both secondary and primary care. In her current role as consultant pharmacist for anticoagulation she leads and promotes quality anticoagulation at local, regional and national levels. Frances chairs the Pan-London Quality Anticoagulation in Atrial Fibrillation Working Group which aims to both increase rates of appropriate anticoagulation amongst Atrial Fibrillation patients and optimise anticoagulation therapy.
Frances is on the expert panel for Anticoagulation UK, a resource for people taking anticoagulant therapy. She currently sits on the NICE Guideline (Update) Committee for Venous Thromboembolic Diseases.
De Vere Grand Connaught Rooms
The closest tube stations are Covent Garden (Piccadilly line) and Holborn on the Central line, both within easy walking distance. London Euston, Kings Cross, and St Pancras International stations are under a 30-minute walk or a short taxi ride away. All of London’s remaining mainline stations are easily reached by the underground network.
Registration is free for healthcare professionals within the UK who have a special interest in AF. Please note that spaces are limited and available on a first-come first-served basis.